AIM: Ampullary adenomas have the potential to progress from benign to malignant lesions. Endoscopic ampullectomy as curative therapy has gained credibility as a safe and effective alternative to surgical resection. This study was designed to assess outcomes of endoscopic resection of ampullary neoplasms at a single center. METHODS: Between May 1996 and August 2009, all patients referred to our center for endoscopic resection of an ampullary lesion were retrospectively identified. Patients were followed for complications and endoscopic surveillance performed per protocol to assess for recurrence. RESULTS: Endoscopic ampullectomy for adenoma was performed in 38 patients (22 females; mean age, 54.3 years, range, 22-85 years), with high-grade dysplasia (HGD) diagnosed in 6 and low-grade dysplasia (LGD) in 32. A direct relationship was observed between HGD and tumor size (P = 0.03). Lesions less than 2.5 cm in size demonstrated no evidence of invasion. Mean follow-up duration was 17.2 ± 2 months (range, 0-82.5 months). Complications were uniformly mild and occurred in 6 (16%) patients: bleeding in 2, pancreatitis in 3, and infection in 1. Adenoma recurrence was documented in 6 (16%) patients, 4 with LGD and 2 with HGD; no patients had tumors that progressed from LGD to HGD or HGD to cancer. Kaplan-Meier analysis showed insignificant differences in recurrence between HGD and LGD groups (P = 0.13). CONCLUSIONS: Endoscopic ampullectomy is a safe and effective treatment for benign ampullary neoplasms and should become the treatment of choice rather than surgical therapy.
AIM: Ampullary adenomas have the potential to progress from benign to malignant lesions. Endoscopic ampullectomy as curative therapy has gained credibility as a safe and effective alternative to surgical resection. This study was designed to assess outcomes of endoscopic resection of ampullary neoplasms at a single center. METHODS: Between May 1996 and August 2009, all patients referred to our center for endoscopic resection of an ampullary lesion were retrospectively identified. Patients were followed for complications and endoscopic surveillance performed per protocol to assess for recurrence. RESULTS: Endoscopic ampullectomy for adenoma was performed in 38 patients (22 females; mean age, 54.3 years, range, 22-85 years), with high-grade dysplasia (HGD) diagnosed in 6 and low-grade dysplasia (LGD) in 32. A direct relationship was observed between HGD and tumor size (P = 0.03). Lesions less than 2.5 cm in size demonstrated no evidence of invasion. Mean follow-up duration was 17.2 ± 2 months (range, 0-82.5 months). Complications were uniformly mild and occurred in 6 (16%) patients: bleeding in 2, pancreatitis in 3, and infection in 1. Adenoma recurrence was documented in 6 (16%) patients, 4 with LGD and 2 with HGD; no patients had tumors that progressed from LGD to HGD or HGD to cancer. Kaplan-Meier analysis showed insignificant differences in recurrence between HGD and LGD groups (P = 0.13). CONCLUSIONS: Endoscopic ampullectomy is a safe and effective treatment for benign ampullary neoplasms and should become the treatment of choice rather than surgical therapy.
Authors: Douglas G Adler; Waqar Qureshi; Raquel Davila; S Ian Gan; David Lichtenstein; Elizabeth Rajan; Bo Shen; Marc J Zuckerman; Robert D Fanelli; Trina Van Guilder; Todd H Baron Journal: Gastrointest Endosc Date: 2006-12 Impact factor: 9.427
Authors: P Katsinelos; G Paroutoglou; J Kountouras; A Beltsis; B Papaziogas; K Mimidis; C Zavos; S Dimiropoulos Journal: Surg Endosc Date: 2006-02-27 Impact factor: 4.584
Authors: R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe Journal: Gut Date: 2000-08 Impact factor: 23.059
Authors: Shayan Irani; Andrew Arai; Kamran Ayub; Thomas Biehl; John J Brandabur; Russell Dorer; Michael Gluck; Geoffrey Jiranek; David Patterson; Drew Schembre; L William Traverso; Richard A Kozarek Journal: Gastrointest Endosc Date: 2009-07-15 Impact factor: 9.427
Authors: Min Kyu Jung; Chang Min Cho; Soo Young Park; Seong Woo Jeon; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Yong Hwan Choi Journal: Surg Endosc Date: 2009-04-10 Impact factor: 4.584
Authors: Wim Laleman; Annelies Verreth; Baki Topal; Raymond Aerts; Mina Komuta; Tania Roskams; Schalk Van der Merwe; David Cassiman; Frederik Nevens; Chris Verslype; Werner Van Steenbergen Journal: Surg Endosc Date: 2013-05-25 Impact factor: 4.584
Authors: Tianle Ma; Eun Jeong Jang; Lawrence R Zukerberg; Robert Odze; Manish K Gala; Peter B Kelsey; David G Forcione; William R Brugge; Brenna W Casey; Sapna Syngal; Daniel C Chung Journal: Surg Endosc Date: 2014-02-25 Impact factor: 4.584
Authors: Bertrand Napoléon; M Victoria Alvarez-Sanchez; Philippe Leclercq; François Mion; Jean Pialat; Rodica Gincul; Daniel Ribeiro; Marie Cambou; Christine Lefort; Mar Rodríguez-Girondo; Jean Yves Scoazec Journal: Surg Endosc Date: 2013-04-03 Impact factor: 4.584
Authors: Marcus Hollenbach; Einas Abou Ali; Francesco Auriemma; Aiste Gulla; Christian Heise; Sara Regnér; Sébastien Gaujoux Journal: Front Med (Lausanne) Date: 2020-05-06
Authors: Woo Ik Chang; Yang Won Min; Hwan Sic Yun; Kwang Hyuck Lee; Jong Kyun Lee; Kyu Taek Lee; Poong Lyul Rhee Journal: Gut Liver Date: 2014-05 Impact factor: 4.519
Authors: Jared J Rejeski; Sarba Kundu; Matthew Hauser; Jason D Conway; John A Evans; Rishi Pawa; Girish Mishra Journal: Endosc Ultrasound Date: 2016 May-Jun Impact factor: 5.628